Cognition Therapeutics, Inc.

CGTX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$7-$8-$8
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$1$0-$2-$1
Other Non-Cash$1$0$0$0
Operating Cash Flow-$6-$6-$10-$8
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$34$1$1$12
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$0
Financing Cash Flow$34$1$1$11
Forex Effect$0$0$0$0
Net Chg. in Cash$28-$5-$9$3
Supplemental Information
Beg. Cash$12$16$25$22
End Cash$40$12$16$25
Free Cash Flow-$6-$6-$10-$8
Cognition Therapeutics, Inc. (CGTX) Financial Statements & Key Stats | AlphaPilot